uropidil
Small moleculeexperimental
Clinical trial activity
8 trials · 17 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00226096)
Timeline
Indications
Mechanism of action
HTR1A agonist
Chemistry & pharmacology
Loading structure…
SMILES
COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1- Mol. weight
- 387.48 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL279229 ↗
Also known as
- 6-((3-(4- (2-methoxyphenyl)-1-piperazinyl)propyl)amino)- 1,3-dimethyl-2,4(1h,3h)-pyrimidinedione
- 6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil
- ebrantil
- ebrantil
- eupressyl
- mediatensyl
- urapidil
- urapidil
- urapidil
- urapidil
- urapidil
- urapidil
- urapidil
- urapidil, 2,3-(14)c2-labeled
- urapidil, 5-(14)c-labeled
- urapidil hcl
- urapidil hydrochloride
- urapidil hydrochloride
- urapidil monohydrochloride
- uraprene
- uropidil
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06609993 | N/A | Dec 12, 2017 | Silesian University of Medicine |
| NCT03001739 | Phase 1 | Dec 1, 2016 | Zhejiang University |
| NCT02857153 | N/A | Jul 1, 2016 | Guizhou Medical University, Henan Medical University, Jinan University, Kunming Medical University, Shiyan Taihe Hospital, Sichuan University, The Second Clinical Medical College of Jinan University |
| NCT02558023 | Phase 3 | Sep 1, 2015 | University of Strasbourg |
| NCT01422616 | Phase 3 | Mar 1, 2012 | Conselho Nacional de Desenvolvimento Científico e Tecnológico, Government of Korea, National Health and Medical Research Council, Australia, Takeda, The Stroke Association, United Kingdom, University of New South Wales |
| NCT01311414 | N/A | Mar 7, 2011 | Universitaetsklinikum Schleswig-Holstein |
| NCT00409253 | Phase 3 | Jun 1, 2007 | University of Strasbourg |
| NCT00226096 | N/A | Nov 1, 2005 | National Health and Medical Research Council, Australia, University of New South Wales |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (17)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Health and Medical Research Council, Australia | Government | 2 | 0 | 2 | 2005 |
| University of New South Wales | Academic/Hospital | 2 | 2 | 2 | 2005 |
| University of Strasbourg | Academic/Hospital | 2 | 2 | 1 | 2007 |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Government | 1 | 0 | 1 | 2012 |
| Government of Korea | Government | 1 | 0 | 1 | 2012 |
| Guizhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Jinan University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Kunming Medical University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Shiyan Taihe Hospital | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Silesian University of Medicine | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Takeda | For profit | 1 | 0 | 1 | 2012 |
| The Second Clinical Medical College of Jinan University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| The Stroke Association, United Kingdom | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Universitaetsklinikum Schleswig-Holstein | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2016 |
17 organizations
Page 1 / 1